Paper41574686
BETMB: A Dual-Target Compound for Synergistic Suppression of Neuronal Hyperexcitability in Refractory Epilepsy via Concurrent Modulation of Nav Channels and GABAA Receptors.
Zhang D and 7 others. CNS Neurosci Ther, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. BETMB: A Dual-Target Compound for Synergistic Suppression of Neuronal Hyperexcitability in Refractory Epilepsy via Concurrent Modulation of Nav Channels and GABAA Receptors. Papers, record 41574686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41574686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- BETMB: A Dual-Target Compound for Synergistic Suppression of Neuronal Hyperexcitability in Refractory Epilepsy via Concurrent Modulation of Nav Channels and GABAA Receptors.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, GABA-A | Major topic |
| Anticonvulsants | Major topic |
| Neurons | Major topic |
| Drug Resistant Epilepsy | Major topic |
| Animals | |
| Mice | |
| Male | |
| Mice, Inbred C57BL |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31214106 | The Concept of Drug-Resistant Epileptogenic Zone. | Front Neurol | 2019 | https://conductscience.org/library/papers/31214106 | PubMed |
| 2 | 15946327 | Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. | Epilepsia | 2005 | https://conductscience.org/library/papers/15946327 | PubMed |
| 3 | 30262417 | Brain-derived neurotrophic factor and epilepsy: a systematic review. | Neuropeptides | 2018 | https://conductscience.org/library/papers/30262417 | PubMed |
| 4 | 21575722 | Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. | Neurobiol Dis | 2011 | https://conductscience.org/library/papers/21575722 | PubMed |
| 5 | 35538233 | Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus. | Nat Rev Neurol | 2022 | https://conductscience.org/library/papers/35538233 | PubMed |
| 6 | 33070315 | High concordance between hippocampal transcriptome of the mouse intra-amygdala kainic acid model and human temporal lobe epilepsy. | Epilepsia | 2020 | https://conductscience.org/library/papers/33070315 | PubMed |
| 7 | 21719429 | Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. | Brain | 2011 | https://conductscience.org/library/papers/21719429 | PubMed |
| 9 | 9596203 | Lamotrigine and seizure aggravation in severe myoclonic epilepsy. | Epilepsia | 1998 | https://conductscience.org/library/papers/9596203 | PubMed |
| 10 | 11163887 | BDNF and epilepsy: too much of a good thing? | Trends Neurosci | 2001 | https://conductscience.org/library/papers/11163887 | PubMed |
| 11 | 24184743 | The kainic acid model of temporal lobe epilepsy. | Neurosci Biobehav Rev | 2013 | https://conductscience.org/library/papers/24184743 | PubMed |
| 12 | 31755112 | Segregation of seizures and spreading depolarization across cortical layers. | Epilepsia | 2019 | https://conductscience.org/library/papers/31755112 | PubMed |
| 13 | 21763207 | Antiepileptic drug therapy: does mechanism of action matter? | Epilepsy Behav | 2011 | https://conductscience.org/library/papers/21763207 | PubMed |
| 14 | 26481038 | A Peptide Uncoupling BDNF Receptor TrkB from Phospholipase Cγ1 Prevents Epilepsy Induced by Status Epilepticus. | Neuron | 2015 | https://conductscience.org/library/papers/26481038 | PubMed |
| 15 | 31823867 | Astrocytic modulation of potassium under seizures. | Neural Regen Res | 2020 | https://conductscience.org/library/papers/31823867 | PubMed |
| 16 | 17040113 | Combination therapy in epilepsy: when and what to use. | Drugs | 2006 | https://conductscience.org/library/papers/17040113 | PubMed |
| 17 | 28807784 | Gabapentin prevents cortical spreading depolarization-induced disinhibition. | Neuroscience | 2017 | https://conductscience.org/library/papers/28807784 | PubMed |
| 18 | 27317657 | Recording, analysis, and interpretation of spreading depolarizations in neurointensive care: Review and recommendations of the COSBID research group. | J Cereb Blood Flow Metab | 2017 | https://conductscience.org/library/papers/27317657 | PubMed |
| 19 | 24368193 | Spreading depression triggers ictaform activity in partially disinhibited neuronal tissues. | Exp Neurol | 2014 | https://conductscience.org/library/papers/24368193 | PubMed |
| 20 | 34575558 | The GluN2B-Selective Antagonist Ro 25-6981 Is Effective against PTZ-Induced Seizures and Safe for Further Development in Infantile Rats. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34575558 | PubMed |
| 21 | 17310035 | GABAA receptor heterogeneity, function, and implications for epilepsy. | Neurology | 2007 | https://conductscience.org/library/papers/17310035 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41574686 | BETMB: A Dual-Target Compound for Synergistic Suppression of Neuronal Hyperexcitability in Refractory Epilepsy via Concurrent Modulation of Nav Channels and GABAA Receptors. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/41574686 |
Source PubMed
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AIF1 | 199 | PubTator's text mining | https://conductscience.org/library/genes/199 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ATP2A2 | 488 | PubTator's text mining | https://conductscience.org/library/genes/488 | NCBI Gene |
| BDNF | 627 | PubTator's text mining | https://conductscience.org/library/genes/627 | NCBI Gene |
| CREB1 | 1385 | PubTator's text mining | https://conductscience.org/library/genes/1385 | NCBI Gene |
| GABARAP | 11337 | PubTator's text mining | https://conductscience.org/library/genes/11337 | NCBI Gene |
| GABRA1 | 2554 | PubTator's text mining | https://conductscience.org/library/genes/2554 | NCBI Gene |
| GRIN2B | 2904 | PubTator's text mining | https://conductscience.org/library/genes/2904 | NCBI Gene |
| RBFOX3 | 146713 | PubTator's text mining | https://conductscience.org/library/genes/146713 | NCBI Gene |
| SCN1A | 6323 | PubTator's text mining | https://conductscience.org/library/genes/6323 | NCBI Gene |
| SMPD1 | 6609 | PubTator's text mining | https://conductscience.org/library/genes/6609 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41574686
GET https://conductscience.org/api/papers/v1/41574686/references?page=2